Echo Therapeutics, Inc. (OTC BB: ECTE)

Echo Therapeutics, Inc. (OTC BB: ECTE) has their focus on thelate-stage development of transdermal diagnostic devices as well as specialty pharmaceuticals. The company is currently developing a needle-free, transdermal continuous glucose monitoring system in conjunction with novel transdermal reformulations of existing FDA-approved products. Echo Therapeutics hopes to change the paradigm of invasive, episodic glucose testing in diabetes home use and hospital critical care markets. For further information, visit the Company’s web site at www.echotx.com.